January 12, 2017 / 7:36 AM / 8 months ago

BRIEF-EyeGene receives patent

Jan 12 (Reuters) - EyeGene Inc :

* Says it received U.S. patent on Jan. 12, for vaccines for cervical cancer

* Says patent number is 13/379,212

Source text in Korean: goo.gl/2SJe8v

Further company coverage: (Beijing Headline News)

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below